DOCTORS'
Medical Case Studies
DOCTORS'
Medical Case Studies
Lenalidomide (Revlimid)
Lenalidomide
Lenalidomide, initially known as CC-5013 and marketed as Revlimid by Celgene, is a derivative of thalidomide introduced in 2004. It was initially intended as a treatment for multiple myeloma, for which thalidomide is an accepted therapeutic treatment. Lenalidomide has also shown efficacy in the class of hematological disorders known as myelodysplastic syndromes (MDS). Lenalidomide and bortezomib are considered therapeutic breakthroughs in the treatment of myeloma, which generally carries a poor prognosis.
Lenalidomide (Revlimid) - List of case studies
- Drugs
-
Laser treatment Lasix Lederfolin Lenalidomide Lenalidomide (Revlimid) Lenalidomide (Revlimid) Lentokalium Lercanidipine ...
- MDS – Myelodysplastic Syndrome
-
the treating options are erythopoietin injections, lenalidomide, Vidaza or Dacogen therapy, or stem cell transplantation. ... 3) Occasional patients will respond to lenalidomide (Revlimid). This is particularly true if there is a chromosome 5 abnormality, ...
- Multiple Myeloma (MM) and Cardiomyopathy
-
bortezomib for later disease stages, or using revlimid (lenalidomide) with or without dexamthasone ( RevDex ) exist – the ... recently approved medications (bortezomib, thalidomide, lenalidomide, doxil) in various combinations and dosing, as well as temporal ...
- Myelodysplastic syndrome (MDS), with kariotype del(11)q(11)
-
are depressed. 3) Occasional patients will respond to lenalidomide (Revlimid) . This is particularly true if there is a chromosome 5 ...
- Pancytopenia of uncertain pathogenesis
-
suppression (Globulins / ATG, cyclosporine); Thalidomide; Lenalidomide; Chemotherapy; Decitabine; 5-aza-cytabine – just to name a ... Pantorc (20 mg), Erythropoietin , Thalidomide, Lenalidomide , Decitabine , 5-aza-cytabine, Revlimid ...
- IgG Multiple Myeloma
-
To a large extent, many of us now preferentially use lenalidomide (Revlimid), since it is somewhat more potent, less sedating, and not ...
- Multiple myeloma with renal involvement, bone lesions and Neuropathy
-
– can also be administered. Lenalidomide (Revlimid) , as a single agent, or better in a combination, usually with ...